COMMUNIQUÉS West-GlobeNewswire

PhotoniCare Announces a First Close of $4.6 Million in Series B Financing, a Manufacturing Partnership with Gentex Corporation, and Relocation of its Headquarters to Grand Rapids, Michigan
03/12/2024
GRAND RAPIDS, Mich., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PhotoniCare Inc., a medical device company dedicated to delivering innovation to frontline care that demonstrably enhances patient outcomes, is pleased to announce [...]
Kno2 announces new PreCheck system to improve patient data security and accuracy
03/12/2024
New system reduces the need to store patient data and accelerates patient matching processes BOISE, Idaho, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Kno2®, the leader in healthcare communication, is proud to announce Kno2 [...]
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
03/12/2024
Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ), a U.S.-based biotechnology company [...]
Corza Medical named #14 on Top 100 Healthcare Technology Companies of 2024
03/12/2024
WESTWOOD, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”), a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, was [...]
H.H.C. Group Supports Self-Insured Stakeholders with Rapid Turnaround Cost-Containment Solutions to Address High Volume of Year-End Claims
03/12/2024
ROCKVILLE, Md., Dec. 03, 2024 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C), the leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]
Brain Cancer Canada, a leading advocate in the fight against brain cancer, is proud to award a $100,000 research grant to one of Canada’s top neuropathologists to support research on one of the deadliest pediatric brain cancers
03/12/2024
TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to announce a $100,000 pediatric research grant awarded to Dr. Cynthia Hawkins, neuropathologist-scientist, and her team at the Hospital for Sick [...]
Upgrade of revenue and operating profit guidance
03/12/2024
ANNOUNCEMENT NO. 285 3 December 2024 Upgrade of revenue and operating profit guidance ChemoMetec sustained its positive performance in the second quarter of 2024/25 with better-than-expected sales and order intake. [...]
HealthEquity 2025 Benefits Trends Unveiled: Cost Transparency and Containment Take Center Stage for Administrators
03/12/2024
SHRM-hosted event will focus on tactics and takeaways to help employers combat rising costs that affect employee satisfaction and benefits utilization DRAPER, Utah, Dec. 03, 2024 (GLOBE NEWSWIRE) -- HealthEquity has [...]
BioAdaptives, Inc.’s Board of Directors Approves a One-for-One Stock Dividend
03/12/2024
LAS VEGAS, Dec. 03, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) Board of Directors has approved a dividend to all common stockholders. They will receive matching shares for all of the shares they [...]
Hapbee Unveils Revolutionary Digital Sleep Solution to Address the Global Sleep Crisis
03/12/2024
VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), a leader in digital wellness technology, is proud to announce [...]
KYZATREX® (testosterone undecanoate) CIII Capsules EXPANDS DISTRIBUTION THROUGH NEW COLLABORATION WITH GAMEDAY MEN’S HEALTH
03/12/2024
The Deal Gives Gameday Men’s Health Patients Access to The FDA-Approved Oral Testosterone Therapy At 250+ Health Centers RALEIGH, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Gameday Men’s Health , the leader in men’s health [...]
Philips aims to advance cardiac MRI technology through AI-driven research
03/12/2024
December 3, 2024 Collaboration intends to leverage proprietary AI technology from Philips and Mayo Clinic to target breakthroughs in ease-of-use and efficiency to bring high-quality diagnostic MRI and better care to [...]
Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed
03/12/2024
HRC Fertility to begin providing FemaSeed infertility treatment to patients at centers across California ATLANTA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on [...]
Aeroflow Health Announces Giving Tuesday Donations to Organizations in Western North Carolina
03/12/2024
Aeroflow donates a total of $25,000 across five local organizations based in its home state ASHEVILLE, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aeroflow Health, a pioneering healthcare company that leverages cutting-edge [...]
Soda Health closes oversubscribed $50M Series B led by General Catalyst to scale its Smart Benefits Operating System
03/12/2024
The fundraise will enable Soda Health to broaden its offering of data products and services, and expand its support to new benefit categories BENTONVILLE, Ark., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Soda Health , a health [...]
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market
03/12/2024
Analysis projects 21% annual growth, with global sales expected to reach $39 billion by 2030. FRAMINGHAM, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global advisory and clinical research firm dedicated to [...]
Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI®
03/12/2024
SOLANA BEACH, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI [...]
Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations
03/12/2024
GLEN ALLEN, Va., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]
Dentsply Sirona to Participate in the 7th Annual Evercore ISI HealthCONx Conference
03/12/2024
CHARLOTTE, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 7 th Annual Evercore ISI HealthCONx [...]

Pages